Search by Drug Name or NDC
NDC 00409-6482-01 Erythrocin Lactobionate 500 mg/10mL Details
Erythrocin Lactobionate 500 mg/10mL
Erythrocin Lactobionate is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ERYTHROMYCIN LACTOBIONATE.
Product Information
| NDC | 00409-6482 |
|---|---|
| Product ID | 0409-6482_94c8bf36-909a-49ad-8b24-53101c3c41c0 |
| Associated GPIs | 03100050502105 |
| GCN Sequence Number | 009252 |
| GCN Sequence Number Description | erythromycin lactobionate VIAL 500 MG INTRAVEN |
| HIC3 | W1D |
| HIC3 Description | MACROLIDE ANTIBIOTICS |
| GCN | 40601 |
| HICL Sequence Number | 004020 |
| HICL Sequence Number Description | ERYTHROMYCIN LACTOBIONATE |
| Brand/Generic | Brand |
| Proprietary Name | Erythrocin Lactobionate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ERYTHROMYCIN LACTOBIONATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/10mL |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA050609 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-6482-01 (00409648201)
| NDC Package Code | 0409-6482-01 |
|---|---|
| Billing NDC | 00409648201 |
| Package | 10 VIAL in 1 TRAY (0409-6482-01) / 10 mL in 1 VIAL (0409-6482-11) |
| Marketing Start Date | 2005-05-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |